What happened: Former world number 39 Marinko Matosevic receives a four-year doping ban from tennis's global integrity agency, which he had labelled "corrupt" during its investigation.
What to watch next: movement around transfusions, australian.

High-Risk Beta
This platform is experimental. Smart contracts are unaudited. Use at your own risk.
ABC Australia focuses on transfusions and australian, with context pulled from source reporting instead of recycled feed copy.
What happened: Former world number 39 Marinko Matosevic receives a four-year doping ban from tennis's global integrity agency, which he had labelled "corrupt" during its investigation.
What to watch next: movement around transfusions, australian.
Verbatim descriptions from source feeds — unedited, as received
ABC Australia(lean-left)
Former world number 39 Marinko Matosevic receives a four-year doping ban from tennis's global integrity agency, which he had labelled "corrupt" during its investigation.
Read full original ›The Defiant(center)
Australia's Senate Economics Legislation Committee has endorsed proposed legislation to modernize the country's digital assets regulatory framework.
Read full original ›2 sources · 2 evidence links
Swarm Claim
Australian Senate committee backs digital assets regulatory framework: Senate Economics Legislation Committee.
ABC Australia · link
Australian tennis coach cops doping ban after admitting blood transfusionsFormer world number 39 Marinko Matosevic receives a four-year doping ban from tennis's global integrity agency, which he had labelled "corrupt" during its investigation.
The Defiant · link
Australian Senate committee backs digital assets regulatory framework: Senate Economics Legislation CommitteeAustralia's Senate Economics Legislation Committee has endorsed proposed legislation to modernize the country's digital assets regulatory framework.
Australia's Senate Economics Legislation Committee has endorsed proposed legislation to modernize the country's digital assets regulatory framework.
Connect your wallet to join the discussion.
No comments yet. Be the first to share your take.